Aloke Finn, MD
CVPath Institute, Gaithersburg, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
Dr. Finn is an interventional cardiologist and internationally recognized expert in the field of vascular biology and vascular device research. He currently serves as Medical Director and Chief of Research of CVPath and is head of the Institute’s basic and translational research laboratory. He is also an Associate Professor of Medicine at the University of Maryland, where he serves (part-time) as a cardiologist and interventional cardiologist.
He has published over 100 peer-reviewed research articles, editorials, and reviews. He is an editorial board member of Coronary Artery Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, Cardiovascular Revascularization Medicine, and Journal of Thoracic Disease. He has also served as Associate Editor for the CathSAP 5 (Basic Science Section), the American College of Cardiology Interventional Cardiology Preperation Course. He is board certified in internal medicine, cardiovascular disease and interventional cardiology.
His research interests are in the area of vascular biology, particularly human vascular disease. He has focused in particular on 1) the molecular mechanisms by which mTOR inhibitors delay endothelial recovery and function after vascular injury; 2) the role of alternative macrophage phenotypes in human atherosclerosis; 3) preclinical research in drug delivery as it relates to both drug-eluting stents and drug-eluting balloons; and 4) pathologic responses to structural heart devices.
He obtained his MD from Vanderbilt University in 2000. During medical school, he received a Howard Hughes Medical Student Research Fellowship and studied vascular gene therapy under David Dichek at the University of California at San Francisco. Dr. Finn did his internal medicine, cardiology and interventional cardiology training at the Massachusetts General Hospital in Boston, including two years of vascular biology research with Drs. Herman Gold and Rakesh Jain. Dr. Finn came to CVPath from Emory University in Atlanta where, from 2007 through 2015, he was Assistant Professor of Medicine and directed a basic and translational research laboratory.